STAMFORD, Conn.–(BUSINESS WIRE)–Point72 Asset Management, L.P. (Point72) has been honored for creating a healthy workplace by the Business Council of Fairfield County. Point72 was recognized for its robust Health and Wellness Program which focuses on…
Category: Business
One-year Outcomes Data from Clinical Trial with ReVision Optics’ Raindrop® Near Vision Inlay for Treating Presbyopia Published in Ophthalmology, the Journal of the American Academy of Ophthalmology
LAKE FOREST, Calif.–(BUSINESS WIRE)–ReVision Optics, Inc., a leader in implantable presbyopia-correcting corneal inlay technology, announces that results from its ongoing Phase III U.S. FDA clinical study evaluating the Raindrop Near Vision Inlay for the treatment of presbyopia show significantly improved near visual performance and produced a 92% rate of satisfaction among study subjects one year following the procedure. The outcomes data were published in an article entitled “Treatment of P
Inotek Pharmaceuticals Strengthens Patent Estate for Lead Product Candidate Trabodenoson
LEXINGTON, Mass.–(BUSINESS WIRE)–Inotek announced that the United States Patent and Trademark Office (“USPTO”) issued a new composition of matter patent for its lead product candidate, trabodenoson.
Ophthotech Corporation to Present at Barclays Global Healthcare Conference 2016
NEW YORK–(BUSINESS WIRE)–Ophthotech announced that David R. Guyer, M.D., Chief Executive Officer and Chairman of the Board, will present at the Barclays Global Healthcare Conference 2016 in Miami on Tuesday, March 15, 2016.
NovaBay Pharmaceuticals to Present at 28th Annual ROTH Conference
EMERYVILLE, Calif.–(BUSINESS WIRE)–NovaBay Pharmaceuticals to present at ROTH conference
Evolution of Microinvasive Glaucoma Surgery Will Expedite the Global Glaucoma Surgical Devices Market Through 2020
LONDON–(BUSINESS WIRE)–The global glaucoma surgical devices market is expected to reach USD 3.11 billion by 2020, growing at a CAGR of close to 41%, according to Technavio’s latest report.
Bruker Introduces New Analytical Solutions and Scientific Instruments at Pittcon 2016
ATLANTA–(BUSINESS WIRE)–This week at Pittcon 2016, Bruker (NASDAQ: BRKR) is showcasing new products and analytical solutions for core Applied & Pharma markets, for our Nanoanalysis, Microscopy & Advanced Materials Research markets, as well as new after-market services and life-cycle support solutions for our customers. A. Applied and Pharmaceutical Markets The new MATRIX™-MG series of high-performance gas analyzers offer automated, high precision and real-time monitoring of gas compou
NovaBay Pharmaceuticals Reports 2015 Fourth Quarter and Full Year Financial Results
EMERYVILLE, Calif.–(BUSINESS WIRE)–NovaBay® Pharmaceuticals, Inc. (NYSE MKT: NBY), a biopharmaceutical Company focusing on commercializing its prescription Avenova® Lid and Lash Cleanser for the domestic eye care market, reports financial results for the three and 12 months ended December 31, 2015, and provides a business update. Fourth Quarter 2015 versus Third Quarter 2015 Avenova Highlights 41% increase in sales to a record $1.6 million 29% increase in the number of optometrists and ophtha
Second Sight Reports Fourth Quarter and Year End 2015 Financial Results
SYLMAR, Calif.–(BUSINESS WIRE)–Second Sight Medical Products, Inc. (NASDAQ: EYES) (“Second Sight” or “the Company”), a developer, manufacturer and marketer of implantable visual prosthetics to provide some useful vision to blind patients, today repor…
Global Contact Lenses & Intraocular Lenses Market – Expected to Grow to US$ 20,050.9 Million by 2019 at a CAGR of 8.4% – Research and Markets
DUBLIN–(BUSINESS WIRE)–Research and Markets (http://www.researchandmarkets.com/research/nhqn5v/global_contact) has announced the addition of the “Global Contact Lenses & Intraocular Lenses Market Assessment & Forecast: 2015-2019” report to their offering. The North American market is anticipated to continue leading in terms of value due to ease of availability, higher awareness and diagnosis, greater number of ophthalmologists and optometrists per 1000 people as compared to other regi
Glaukos to Present at 28th Annual Roth Conference
LAGUNA HILLS, Calif.–(BUSINESS WIRE)–Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures designed to transform the treatment of glaucoma, …
First Patients in Presbia Microlens FDA Study Complete 12-Month Postoperative Visits
DUBLIN–(BUSINESS WIRE)–Presbia PLC (NASDAQ: LENS), an ophthalmic device company and leader in near-vision restoration, announced today that all subjects treated as part of the first stage of its U.S. Food and Drug Administration (FDA) pivotal study completed their 12-month postoperative visits, a significant milestone in the FDA approval process of its Presbia Flexivue Microlens™. The Presbia Flexivue Microlens is a revolutionary optical lens implant for treating presbyopia, the age-related l
Second Sight to Discuss Fourth Quarter and Year End 2015 Financial Results on March 3, 2016 Conference Call
SYLMAR, Calif.–(BUSINESS WIRE)–Second Sight Medical Products, Inc. (NASDAQ:EYES), a developer, manufacturer and marketer of implantable visual prosthetics to provide some useful vision to blind patients, will release its fourth quarter and year end 2…
Clearside Biomedical, Inc. Announces Appointment of Richard J. Croarkin to the Board of Directors
ALPHARETTA, Ga.–(BUSINESS WIRE)–Clearside Biomedical, a late-stage clinical biopharmaceutical company developing first-in-class drug therapies for the eye, announces that Richard J. Croarkin is joining its Board of Directors.
ACADIA Pharmaceuticals Reports Financial Results for the Fourth Quarter and Year Ended December 31, 2015
SAN DIEGO–(BUSINESS WIRE)–ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD), a biopharmaceutical company focused on the development and commercialization of innovative medicines to address unmet medical needs in central nervous system disorders, today announced its financial results for the fourth quarter and year ended December 31, 2015. “2015 was highlighted by the filing of our NUPLAZID™ (pimavanserin) New Drug Application for Parkinson’s disease psychosis and the designation of Priority Review b
Inotek Pharmaceuticals to Present at Cowen and Company’s 36th Annual Health Care Conference
LEXINGTON, Mass.–(BUSINESS WIRE)–David P. Southwell, President and CEO of Inotek, will present at Cowen and Company’s 36th Annual Health Care Conference on Monday, March 7th, 2016 at 2:00 ET at the Boston Marriott Copley Place Hotel
Notal Vision Achieves Medicare Coverage For ForeseeHome
CHANTILLY, Va.–(BUSINESS WIRE)–Notal Vision, Inc. is pleased to announce that the ForeseeHome AMD Monitoring Program is now available for eligible Medicare patients across the U.S. ForeseeHome is available by prescription for patients with Dry Age-related Macular Degeneration (AMD) at high risk for developing Wet AMD. The clinical utility for ForeseeHome was established in the Home Monitoring of the Eye (HOME) Study, part of a National Eye Institute-sponsored study, where over 1500 patients w
Second Sight Mourns Loss and Celebrates Legacy of Founder Alfred E. Mann
SYLMAR, Calif.–(BUSINESS WIRE)–Second Sight Medical Products, Inc. (NASDAQ: EYES) (“Second Sight” or “the Company”), a developer, manufacturer and marketer of implantable visual prosthetics to provide some useful vision to blind patients, today mourns the passing of Founder Alfred E. Mann. “We are all deeply saddened by the loss of our founder, mentor and friend, Al Mann, a pioneering leader whose contributions and vision profoundly impacted the lives of so many and whose legacy will impact m
Cataracts Pipeline – Global API Manufacturers, Marketed and Phase III Drugs Landscape 2016 – Research and Markets
DUBLIN–(BUSINESS WIRE)–Research and Markets (http://www.researchandmarkets.com/research/rnz2xt/cataractglobal) has announced the addition of the “Cataract-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016” report to their offerin…
Inotek Pharmaceuticals Announces Poster Presentation at the American Glaucoma Society’s 2016 Annual Meeting
LEXINGTON, Mass.–(BUSINESS WIRE)–Inotek announced that David S. Albers, Ph.D., Senior Director, Preclinical Research & Development, will present a poster on March 4, 2016 at the American Glaucoma Society’s 2016 Annual Meeting.